P

Inventor

SCHNEIDER HERBERT

DE35 patents
⚠️ This page may combine multiple inventors who share the name “SCHNEIDER HERBERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHERING AG

19 patents
US6025376AFeb 15, 2000

Chiral methylphenyloxazolidinones

SCHERING AG32 citations92
US6855714B2Feb 15, 2005

1-alkyl-2-aryl-benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives

SCHERING AG29 citations91
US6011060AJan 4, 2000

Chiral phenyldihydrofuranones as PDE-IV inhibitors

SCHERING AG27 citations91
US4719210AJan 12, 1988

3-vinyl and 3-thyinyl-beta-carbolines, and their use as benzodiazepine receptor antagonists or agonists

SCHERING AG19 citations82
US5506234AApr 9, 1996

β-carboline derivatives for use as pharmaceutical agents

SCHERING AG18 citations74
US5348958ASep 20, 1994

Hetaryloxy-β-carbolines, and use as pharmaceutical agents for treating epilepsy and anxiety

SCHERING AG11 citations74
US4826852AMay 2, 1989

Novel ergolinyl compounds nitrogen-substituted in the 8-position, useful for treating dopamine deficiency

SCHERING AG15 citations74
US6962932B2Nov 8, 2005

1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives

SCHERING AG6 citations72
US6143733ANov 7, 2000

Quinoxalinedione derivatives, their production and use in pharmaceutical agents

SCHERING AG7 citations72
US4933345AJun 12, 1990

Isoxazole-β-carboline derivatives

SCHERING AG14 citations72
US6117895ASep 12, 2000

Pharmaceutical preparations for TNF inhibition

SCHERING AG9 citations71
US5614509AMar 25, 1997

Pharmaceutical agents for preventing the development of tolerance during the treatment with benzodiazepine-receptor-binding active ingredients

SCHERING AG10 citations71
US5350750ASep 27, 1994

β-carboline-3-hydroxyalkylcarboxylic acid ester derivatives, process for their production and their use in pharmaceutical agents

SCHERING AG2 citations63
US5256682AOct 26, 1993

Isoxazolylimidazole derivatives, process for their production and their use in pharmaceutical agents

SCHERING AG4 citations59
US5698555ADec 16, 1997

Hetaryloxy-β-carbolines, their production and use in pharmaceutical agents

SCHERING AG0 citations51
US4853390AAug 1, 1989

(2-Haloergolinyl)-N'-N'-diethylurea compounds useful as medicinal agents E.G., as neuroleptics

SCHERING AG1 citations51
US7196202B2Mar 27, 2007

1-aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives

SCHERING AG0 citations48
US6903126B2Jun 7, 2005

1-Aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives

SCHERING AG0 citations48
US5543519AAug 6, 1996

3-aryl or 3-hetaryl-β-carbolines, their production and use in pharmaceutical agents

SCHERING AG0 citations42

GRUMMAN AEROSPACE CORP

2 patents

WOLF GMBH RICHARD

1 patent

FIRSCHUNGSZEUTRWM KARLSRUHE GM

1 patent

GUNTER M VOSS

1 patent

BOSCH GMBH ROBERT

1 patent

SUED CHEMIE AG

1 patent

SIEMENS AG

1 patent

STOLL & CO H

1 patent

CONTINENTAL AUTOMOTIVE GMBH

1 patent

PHILIPS CORP

1 patent

SCNERING AG

1 patent

BAYER SCHERING PHARMA AG

1 patent

KARLSRUHE FORSCHZENT

1 patent

SCHERING AKTIIENGESELLSCHAFT

1 patent

PIERBURG GMBH

1 patent